Covidien manufactures, distributes and services a diverse range of medical devices, supplies, imaging products and pharmaceuticals, sold under industry-leading brand names such as Autosuture, Kendall, Mallinckrodt, Nel... 

Charles J. Dockendorff is Executive Vice President and Chief Financial Officer (CFO) at Covidien plc, a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, separated from parent company Tyco International on June 29, 2007.

In this position, Mr. Dockendorff is responsible for the Company’s financial management and activities, including Corporate Accounting, Tax, Treasury, Financial Planning and Investor Relations, as well as Int... 

In this position, Mr. Almeida oversees the Surgical Devices, Energy-based Devices, Respiratory & Monitoring Solutions and Vascular Therapies Global Business Units, as well as the Japan, Asia, Canada and Latin America regions. The... 

In this position, Mr. Wright supervises the company’s management and strategic direction of the $2.5 billion business, which collectively market a broad spectrum of contrast media, nuclear medicine (radiopharmaceuticals) and pharmaceu... 

In this position, Mr. Clemmer directs strategic and day-to-day operations of the Nursing Care, Monitoring & OR Products, SharpSafety and OEM product lines. He is responsible for nearly $2 billion of revenue and the growth of operatin... 

In this position, Mr. Dunford is responsible for Covidien’s global human resources strategies, practices and programs including total rewards, talent management, staffing, HR systems and learning and organizational development.... 

Eric A. Kraus is Senior Vice President of Corporate Communications and Public Affairs at Covidien plc, a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, separated from parent company Tyco International on June 29, 2007.

Mr. Kraus is responsible for directing Covidien's global communications strategies. This encompasses both internal and external communications initiatives worldwide, including corporate marketing, public relat... 

John H. Masterson is Senior Vice President and General Counsel at Covidien, plc, a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, separated from parent company Tyco International on June 29, 2007.

In this position, Mr. Masterson has responsibility for all legal affairs relating to Covidien’s business, including providing legal advice to senior management on business and commercial issues; overseeing litigation matters; lead... 

James M. Muse is Senior Vice President of the Global Supply Chain at Covidien plc, a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, separated from parent company Tyco International on June 29, 2007.

In this position, Mr. Muse manages all strategies related to Covidien’s Global Supply Chain. He directs the strategic, global and day-to-day operations of Customer Service, Strategic Procurement, Working Capital, Inventory Dist... 

Amy A. Wendell is Senior Vice President of Strategy and Business Development at Covidien plc, a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, separated from parent company Tyco International on June 29, 2007.

In this position, Ms. Wendell manages all business development, including acquisitions, divestitures and licensing/distribution, and leads the Company’s strategy and portfolio management initiatives. She played a key... 

Richard G. Brown is Vice President, Corporate Controller and Chief Accounting Officer at Covidien plc, a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, separated from parent company Tyco International on June 29, 2007.

In this position, Mr. Brown is responsible for all aspects of accounting operations, including external financial reporting and establishment and enforcement of Covidien’s accounting policies and procedures, ... 

Kevin G. DaSilva is Vice President and Treasurer at Covidien plc, a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, separated from parent company Tyco International on June 29, 2007.

In this position, Mr. DaSilva supervises all aspects of Covidien’s global Treasury function, including equity and debt financing activities in the financial markets, worldwide banking and international funding, capital planning, capital markets,... 

Eric C. Green is Vice President and Chief Tax Officer at Covidien plc, a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, separated from parent company Tyco International on June 29, 2007.

In this position, Mr. Green is responsible for all aspects of tax and for leading Covidien's Global Tax Organization, including the design and implementation of global tax policy and strategies and the creation of a tax department that iden... 

Coleman N. Lannum is Vice President of Investor Relations at Covidien plc, a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, separated from parent company Tyco International on June 29, 2007.

In this position, Mr. Lannum is responsible for developing Covidien’s relationship with shareholders and institutional investors and plays a key role in shaping corporate strategy. He has headed Investor Relations since joining the or... 

Steven M. McManama is Vice President and Global Chief Information Officer (CIO) at Covidien plc, a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, separated from parent company Tyco International on June 29, 2007.

In this position, Mr. McManama provides technology vision and leadership through the development and implementation of the corporate-wide business-driven information technology program. This program includes the r... 

David A. Olson is Vice President of Regulatory Affairs at Covidien plc, a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, separated from parent company Tyco International on June 29, 2007.

In this position, Mr. Olson ensures the Company’s compliance with U.S. Food & Drug Administration regulations, as well as those of international regulatory authorities. This includes working closely with regulatory agencies to develop, f...